XML 33 R14.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Shareholders' Equity and Share-Based Compensation (Notes) | 12 Months Ended
--- | ---
Dec. 31, 2024
Equity [Abstract] |
Shareholders' Equity and Share-based Compensation | SHAREHOLDERS’ EQUITY AND SHARE-BASED COMPENSATION Preferred Stock. The Company’s Board of Directors has designated 6,600,000 shares of the Company’s preferred stock for issuance as Series C Preferred Stock, of which the Company has 4,460,000 of such shares outstanding as of December 31, 2024. The Series C Preferred Stock has no stated maturity, is not subject to any sinking fund or mandatory redemption, and will remain outstanding indefinitely unless redeemed, repurchased, or converted into common stock pursuant to the terms of the Series C Preferred Stock. Except under certain limited circumstances described in Article IIIC of the Company’s Restated Articles of Incorporation, the Company may not redeem the Series C Preferred Stock prior to April 15, 2025. On or after that date, the Series C Preferred Stock may be redeemed at any time and from time to time at the Company's option at a cash redemption price of $25.00 per share plus any accumulated and unpaid dividends. Because the Series C Preferred Stock is redeemable only at the option of the issuer, it is classified as equity on the Company’s consolidated balance sheet. The Series C Preferred Stock pays a cumulative cash dividend equivalent to 6.900% of the $25.00 liquidation preference per share each year until April 15, 2025. Due to the cessation of 3-month LIBOR, the original terms of the Series C Preferred Stock have been revised to state that upon April 15, 2025 and thereafter, the Company will pay cumulative cash dividends at a percentage of the $25.00 liquidation value per share equal to 3-month term SOFR plus the statutorily prescribed tenor spread adjustment of 0.26161% in addition to the original spread pursuant to the terms of the Series C Preferred Stock of 5.461% for a total spread of 5.723%. The Company paid its regular quarterly dividend of $0.43125 per share of Series C Preferred Stock on January 15, 2025 to shareholders of record as of January 1, 2025. Common Stock. During the year ended December 31, 2024, the Company issued 10,500,000 shares of its common stock through a public offering, resulting in proceeds of $124.5 million, net of issuance costs, and issued 16,756,835 shares of its common stock through its at-the-market (“ATM”) program at an aggregate value of $207.6 million, net of broker commissions and fees. The Company declared common dividends of $0.43 on its common stock for the three months ended December 31, 2024 and $1.60 per common share for the year ended December 31, 2024. The Company’s timing, frequency, and amount of dividends declared on its common stock are determined by its Board of Directors. When declaring dividends, the Board of Directors considers the Company’s taxable income, the REIT distribution requirements of the Tax Code, and maintaining compliance with dividend requirements of the Series C Preferred Stock, along with other factors that the Board of Directors may deem relevant from time to time. Share-Based Compensation. The following table presents a rollforward of share-based awards for the periods indicated:
|  | Year Ended
|  | December 31,
|  | 2024 |  | 2023 |  | 2022
Type of Award |  | Shares |  | Weighted Average Grant Date Fair Value Per Share |  | Shares |  | Weighted Average Grant Date Fair Value Per Share |  | Shares |  | Weighted Average Grant Date Fair Value Per Share
Restricted stock: |  |  |  |  |  |  |  |  |  |  |  |
Awards outstanding, beginning of period |  | 104,282 |  |  | $ | 12.61 |  |  | 133,951 |  |  | $ | 15.22 |  |  | 197,804 |  |  | $ | 15.27 |
Granted |  | 65,668 |  |  | 12.56 |  |  | 74,017 |  |  | 11.27 |  |  | 71,216 |  |  | 15.60 |
Vested |  | (76,355) |  |  | 12.37 |  |  | (103,686) |  |  | 15.03 |  |  | (135,069) |  |  | 15.49 |
Awards outstanding, end of period |  | 93,595 |  |  | $ | 12.78 |  |  | 104,282 |  |  | $ | 12.61 |  |  | 133,951 |  |  | $ | 15.22 |
Target RSUs: (1) |  |  |  |  |  |  |  |  |  |  |  |
Awards outstanding, beginning of period |  | 394,497 |  |  | $ | 13.06 |  |  | 86,666 |  |  | $ | 16.57 |  |  | 55,019 |  |  | $ | 19.40 |
Granted |  | 214,755 |  |  | 12.50 |  |  | 341,044 |  |  | 12.55 |  |  | 73,767 |  |  | 15.19 |
Vested |  | (146,182) |  |  | 13.57 |  |  | (33,213) |  |  | 16.96 |  |  | (42,120) |  |  | 17.85 |
Awards outstanding, end of period |  | 463,070 |  |  | $ | 12.64 |  |  | 394,497 |  |  | $ | 13.06 |  |  | 86,666 |  |  | $ | 16.57 |
Target PSUs: (2) |  |  |  |  |  |  |  |  |  |  |  |
Awards outstanding, beginning of period |  | 276,866 |  |  | $ | 13.17 |  |  | 201,284 |  |  | $ | 16.60 |  |  | 110,040 |  |  | $ | 19.04 |
Granted |  | 322,132 |  |  | 12.50 |  |  | 160,277 |  |  | 11.97 |  |  | 147,542 |  |  | 14.83 |
Vested |  | (116,589) |  |  | 14.83 |  |  | (84,695) |  |  | 19.04 |  |  | (56,298) |  |  | 16.73 |
Awards outstanding, end of period |  | 482,409 |  |  | $ | 12.32 |  |  | 276,866 |  |  | $ | 13.17 |  |  | 201,284 |  |  | $ | 16.60 |
(1)The number of RSUs shown represent the target number of awards. Actual number of shares that will potentially settle may range from 0% if the recipient’s service-based vesting condition is not met to 100% if the service-based vesting condition is met. (2)The number of PSUs shown represent the target number of awards. Actual number of shares that will potentially settle may range from 0% to 200% based on the achievement of the performance goals defined in each grant award. The restricted stock awards outstanding as of December 31, 2024 were all granted to employees except for 38,068 granted to the Company’s non-employee members of its Board of Directors, which have a vesting period of 1 year. Restricted stock granted to employees generally vests in equal installments over a period of 3 years. RSU and PSU awards are granted only to executive officers of the Company. RSUs vest in equal installments over a period of 3 years. PSUs vest based on performance results measured over a period of 3 years. The Company expects 102% of the remaining target PSUs outstanding as of December 31, 2024 will be settled on their vesting dates. The table above excludes 116,589 PSUs with a performance period ending December 31, 2024, of which 75% are expected to be awarded based on information known as of the filing date of this Annual Report on Form 10-K. The Company has DERs accrued for RSUs and PSUs of $0.9 million and $1.3 million, respectively, as of December 31, 2024 compared to $0.4 million and $0.8 million, respectively, as of December 31, 2023, which is included on the Company’s consolidated balance sheet within “accrued dividends payable.” Total share-based compensation expense recognized by the Company for the year ended December 31, 2024 was $7.2 million compared to $4.8 million and $4.4 million for the years ended December 31, 2023 and December 31, 2022, respectively. The increase in share-based compensation for the year ended December 31, 2024 is due to accelerated recognition of expense for certain stock incentive awards granted in March 2024 to retirement eligible employees. The following table discloses the Company’s remaining compensation expense related to stock awards it has granted as of December 31, 2024, which will be amortized over the period disclosed:
| December 31, 2024
($s in thousands) | Remaining Compensation Cost |  | WAVG Period of Recognition
Restricted stock | $ | 564 |  |  | 1.3 years
RSUs | 3,007 |  |  | 1.8 years
PSUs | 1,900 |  |  | 1.8 years
Total | $ | 5,471 |  |  | 1.8 years

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/505/tableOfContent Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent + Details
Name: | us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration